欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号CZ/V/0124/001
药品名称Biocan Novel DHPPi lyophilisate for suspension for injection for dogs
活性成分
    • canine adenovirus 5.3 TCID50
    • canine distemper virus 5.1 TCID50
    • canine parainfluenza virus 5.1 TCID50
    • canine parvovirus 6.6 TCID50
剂型Lyophilisate for suspension for injection
上市许可持有人Bioveta, a.s. Komenskeho 212 683 23 Ivanovice na Hane Czech Republic
参考成员国 - 产品名称Czechia (CZ)
Biocan Novel DHPPi, lyofilizát a rozpouštědlo pro injekční suspenzi pro psy
互认成员国 - 产品名称
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
    • Estonia (EE)
      Biocan Novel DHPPi
    • Hungary (HU)
      Biocan Novel DHPPi vakcina A.U.V.
    • Bulgaria (BG)
    • Cyprus (CY)
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
    • Croatia (HR)
许可日期2014/07/23
最近更新日期2020/04/02
药物ATC编码
    • QI07AD04 canine distemper virus + canine adenovirus + canine parvovirus + canine parainfluenza virus
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：Full dossier - art 12.3 Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase